Similar articles

• Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.

  Johnson RE, Fudala PJ, Jaffe JH. Johnson RE, et al. NIDA Res Monogr. 1990;105:585-6. NIDA Res Monogr. 1990. PMID: 1876130 No abstract available.
• Administration of meptazinol to opiate-dependent patients.

  Evans M, Robson PJ, Chadd MA, Evans CM, Fry DM. Evans M, et al. Postgrad Med J. 1983;59 Suppl 1:78-84. Postgrad Med J. 1983. PMID: 6835896 Clinical Trial.
• Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.

  Kosten TR, Morgan C, Kleber HD. Kosten TR, et al. NIDA Res Monogr. 1992;121:101-19. NIDA Res Monogr. 1992. PMID: 1406906 Clinical Trial. No abstract available.
• Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.

  Gold MS. Gold MS. Psychiatr Clin North Am. 1993 Mar;16(1):61-73. Psychiatr Clin North Am. 1993. PMID: 8456048 Review.
• Opioid dependence: rationale for and efficacy of existing and new treatments.

  Fiellin DA, Friedland GH, Gourevitch MN. Fiellin DA, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. doi: 10.1086/508180. Clin Infect Dis. 2006. PMID: 17109303 Review.